ghk-cu clinical trial injection human Frontiers ghk-cu clinical trial injection The

Studying dual GLP-1/GIP incretin effects tirzepatide

In preclinical models, wound closure is 30 to 40% faster with GHK-Cu than with controls

Weight Regulation In animal studies, AOD-9604 reduced body fat mass and improved metabolic parameters. Early human trials showed limited direct weight loss, but trends toward improved lipid metabolism. Key takeaway: May influence weight management indirectly by altering fat metabolism

For soft tissue research this combination is considered the gold standard

If youre ready to unlock the benefits of B12 injections, consider Sermedspa your trusted partner on the journey to a healthier, more vibrant you

Tirzepatide with niacinamide has gained attention for potential metabolic benefits beyond weight loss